Skip to main content
SpringerLink
Log in

Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zhu AX, Duda DG, Sahani DV, Jain RK. HCC and angiogenesis: possible targets and future directions. Nat rev Clin Oncol. 2011;8:292–301.

    Article  CAS  Google Scholar 

  2. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–71.

    Article  CAS  Google Scholar 

  3. Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008;48:1312–27.

    Article  CAS  Google Scholar 

  4. Hennedige T, Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging. 2013;12:530–47.

    Article  Google Scholar 

  5. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  CAS  Google Scholar 

  6. Nishino M, Jackman DM, Hatabu H, Yeap BY, Cioffredi LA, Yap JT, et al. New response evaluation criteria in solid tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. AJR am J Roentgenol. 2010;195:W221–8.

    Article  Google Scholar 

  7. Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinibmesylate: proposal of new computed tomography response criteria. J ClinOncol. 2007;25:1753–9.

    Article  Google Scholar 

  8. Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin N am. 2009;47:161–78.

    Article  Google Scholar 

  9. Okada M, Kim T, Murakami T. Hepatocellular nodules in liver cirrhosis: state of the art CT evaluation (perfusion CT/volume helical shuttle scan/dual-energy CT, etc.). Abdom Imaging. 2011;36:273–81.

    Article  Google Scholar 

  10. Ogul H, Bayraktutan U, Kizrak Y, Pirimoglu B, Yuceler Z, Sagsoz ME, et al. Abdominal perfusion computed tomography. Eurasian J med. 2013;45:50–7.

    Article  Google Scholar 

  11. Pirimoglu B, Sade R, Ogul H, Kantarci M, ErenS LA. How can new imaging modalities help in the practice of radiology? Eurasian J med. 2016;48:213–21.

    Article  Google Scholar 

  12. Kan Z, Kobayashi S, Phongkitkarun S, Charnsangavej C. Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model. Radiology. 2005;237:144–50.

    Article  Google Scholar 

  13. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol. 2004;11:215–23.

    Article  Google Scholar 

  14. Hagiwara M, Rusinek H, Lee VS, et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging initial experience. J Magn Reson Imaging. 2003;18:372–6.

    Article  Google Scholar 

  15. Chen X, Xiao E, Shu D, Yang C, Liang B, He Z, et al. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging. Eur J Gastroenterol Hepatol. 2014;26:109–13.

    Article  Google Scholar 

  16. Mehdizade A, Somon T, Wetzel S, Kelekis A, Martin JB, Scheidegger JR, et al. Diffusion weighted MR imaging on a low-field open magnet. Comparison with findings at 1.5T in 18 patients with cerebral ischemia. J Neuroradiol. 2003;30:25–30.

    CAS  PubMed  Google Scholar 

  17. Bonekamp S, Jolepalem P, Lazo M, Gulsun MA, Kiraly AP, Kamel IR. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion weighted and contrast-enhanced MR imaging data. Radiology. 2011;260:752–61.

    Article  Google Scholar 

  18. Yu JS, Kim JH, Chung JJ, Kim KW. Added value of diffusion weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. J Magn Reson Imaging. 2009;30:153–60.

    Article  Google Scholar 

  19. Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B. Serial diffusion weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur J Radiol. 2013;82:577–82.

    Article  Google Scholar 

  20. Dijkstra H, Baron P, Kappert P, Oudkerk M, Sijens PE. Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol. 2012;22:891–9.

    Article  Google Scholar 

  21. Watanabe H, Kanematsu M, Goshima S, Kajita K, Kawada H, Noda Y, et al. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T. Acta Radiol. 2014;55:1166–73.

    Article  Google Scholar 

  22. Penner AH, Sprinkart AM, Kukuk GM, Gütgemann I, Gieseke J, Schild HH, et al. Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI. Eur Radiol. 2013;23:2773–83.

    Article  Google Scholar 

  23. Park YS, Lee CH, Kim JH, Kim IS, Kiefer B, Seo TS, et al. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. Magn Reson Imaging. 2014;32:638–46.

    Article  Google Scholar 

  24. Jiang R, Jiang J, Zhao L, Zhang J, Zhang S, Yao Y, et al. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation. Oncotarget. 2015;6:42380–93.

    PubMed  PubMed Central  Google Scholar 

  25. Yuan L, Sun M, Chen Y, Long M, Zhao X, Yin J, et al. Non-Gaussian diffusion alterations on diffusion kurtosis imaging in patients with early Alzheimer’s disease. Neurosci Lett. 2016;616:11–8.

    Article  CAS  Google Scholar 

  26. Goshima S, Kanematsu M, Noda Y, Kondo H, Watanabe H, Bae KT. Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma. AJR am J Roentgenol. 2015;204:543–9.

    Article  Google Scholar 

  27. Martín Noguerol T, Sánchez-González J, Martínez Barbero JP, García-Figueiras R, Baleato-González S, Luna A. Clinical imaging of tumor metabolism with 1H magnetic resonance spectroscopy. Magn Reson Imaging Clin N am. 2016;24:57–86.

    Article  Google Scholar 

  28. Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging. 2004;19:598–604.

    Article  Google Scholar 

  29. Zaidi H, Mawlawi O, Orton CG. Point/counterpoint. Simultaneous PET/MR will replace PET/CT as the molecular multimodality imaging platform of choice. Med Phys. 2007;34:1525–8.

    Article  Google Scholar 

  30. Fowler KJ, Maughan NM, Laforest R, Saad NE, Sharma A, Olsen J, et al. PET/MRI of hepatic 90Y microsphere deposition determines individual tumor response. Cardiovasc Intervent Radiol. 2016;39:855–64.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Faculty of Medicine, Ataturk University, 25040, Erzurum, Turkey

    Mecit Kantarci & Berhan Pirimoglu

Authors
  1. Mecit Kantarci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Berhan Pirimoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mecit Kantarci.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kantarci, M., Pirimoglu, B. Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others. J Gastrointest Canc 48, 282–285 (2017). https://doi.org/10.1007/s12029-017-9969-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-017-9969-y

Keywords

Search

Navigation